What is the current annual D&A of NVS?

As of today, NVS annual D&A is $5.35B

What is 1-year change in NVS annual D&A?

NVS annual D&A is down -11.76% year-over-year

What is 3-year change in NVS annual D&A?

NVS annual D&A is down -20.33% over the past 3 years

How far is NVS annual D&A from its all-time high?

NVS annual D&A is currently -35.34% below its historical high of $8.28B set on December 31, 2023

How does NVS annual D&A rank versus sector peers?

NVS annual D&A is higher than 99.44% of companies in Healthcare sector

When is NVS next annual earnings release?

The next annual earnings release for NVS is on February 3, 2027

What is the current quarterly D&A of NVS?

As of today, NVS quarterly D&A is $3.57B

What is NVS quarterly D&A most recent change?

NVS quarterly D&A was up +155.18% on September 30, 2026

What is 1-year change in NVS quarterly D&A?

NVS quarterly D&A is up +144.07% year-over-year

How far is NVS quarterly D&A from its all-time high?

NVS quarterly D&A is currently at its all-time high

How does NVS quarterly D&A rank versus sector peers?

NVS quarterly D&A is higher than 100.00% of companies in Healthcare sector

When is NVS next earnings release?

The next earnings release for NVS is on February 3, 2027

What is the current TTM D&A of NVS?

As of today, NVS TTM D&A is $7.76B

What is NVS TTM D&A most recent change?

NVS TTM D&A was up +37.33% on September 30, 2026

What is 1-year change in NVS TTM D&A?

NVS TTM D&A is up +43.05% year-over-year

How far is NVS TTM D&A from its all-time high?

NVS TTM D&A is currently -8.94% below its historical high of $8.52B set on September 30, 2023

How does NVS TTM D&A rank versus sector peers?

NVS TTM D&A is higher than 99.89% of companies in Healthcare sector

When is NVS next earnings release?

The next earnings release for NVS is on February 3, 2027

Novartis AG (NVS) Depreciation And Amortization History & Chart

Annual D&A

$5.35B$713.30M-11.76%

December 31, 2025

Summary

Current Value: As of today, NVS annual D&A is $5.35B, down -11.76% on December 31, 2025
Historical Performance: NVS annual D&A is down -20.33% over the past 3 years, up +4.74% over the past 5 years
All-Time High Comparison: NVS annual D&A is currently -35.34% below its historical high of $8.28B set on December 31, 2023
3-Year Low Comparison: NVS annual D&A is at its 3-year low
Sector Comparison: NVS annual D&A is higher than 99.44% of companies in Healthcare sector

Depreciation & Amortization Chart

beforeafter

Performance

NVS Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual D&A	Dec 31, 25	$5.35B	-11.8%	-20.3%	+4.7%	+116.0%
Quarterly D&A	Sep 30, 26	$3.57B	+144.1%	+14.9%	+146.0%	+163.2%
TTM D&A	Sep 30, 26	$7.76B	+43.0%	-8.9%	+58.8%	+99.7%
Price	Nov 6, 26	$162.55	+28.4%	+73.9%	+94.3%	+223.4%
Annual SG&A	Dec 31, 25	$0.00	-100.0%	-100.0%	-100.0%	-100.0%
Annual Total Expenses	Dec 31, 25	$40.76B	+6.3%	+12.5%	+0.4%	+0.6%
Annual Operating Expenses	Dec 31, 25	$24.57B	+11.4%	+20.1%	+8.2%	-7.2%
Annual Revenue	Dec 31, 25	$54.81B	+9.0%	+29.6%	+12.0%	+9.2%

Depreciation & Amortization Highs

NVS Annual D&A Highs Comparison
Period	High	Date	Current
3Y	$8.28B	Dec 31, 23	-35.3%
5Y	$8.28B	Dec 31, 23	-35.3%
All	$8.28B	Dec 31, 23	-35.3%

Depreciation & Amortization Lows

NVS Annual D&A Lows Comparison
Period	Low	Date	Current
3Y	$5.35B	Dec 31, 25	at low
5Y	$5.11B	N/A	+4.7%
All	$890.68M	Dec 1, 97	+500.9%

Depreciation & Amortization History

Year	Value	Change
2025	$5.35B	-11.8%
2024	$6.07B	-26.7%
2023	$8.28B	+23.2%
2022	$6.72B	+23.7%
2021	$5.43B	+6.2%
2020	$5.11B	-12.3%
2019	$5.83B	+11.5%
2018	$5.22B	+0.2%
2017	$5.21B	-2.6%
2016	$5.35B	+2.4%
2015	$5.23B	+19.8%
2014	$4.36B	-6.5%
2013	$4.66B	+1.4%
2012	$4.60B	-2.3%
2011	$4.71B	+89.9%
2010	$2.48B	+9.8%
2009	$2.26B	-1.9%

Year	Value	Change
2008	$2.30B	-19.5%
2007	$2.86B	+48.6%
2006	$1.92B	+14.5%
2005	$1.68B	+26.1%
2004	$1.33B	+4.5%
2003	$1.27B	-1.5%
2002	$1.29B	+24.9%
2001	$1.04B	+16.3%
2000	$890.68M	-11.2%
1999	$1.00B	+4.7%
1998	$957.81M	+7.5%
1997	$890.68M	-43.1%
1996	$1.57B	-1.5%
1995	$1.59B	+16.2%
1994	$1.37B	+5.9%
1993	$1.29B	-

FAQ

What is the current annual D&A of NVS?: As of today, NVS annual D&A is $5.35B
What is 1-year change in NVS annual D&A?: NVS annual D&A is down -11.76% year-over-year
What is 3-year change in NVS annual D&A?: NVS annual D&A is down -20.33% over the past 3 years
How far is NVS annual D&A from its all-time high?: NVS annual D&A is currently -35.34% below its historical high of $8.28B set on December 31, 2023
How does NVS annual D&A rank versus sector peers?: NVS annual D&A is higher than 99.44% of companies in Healthcare sector
When is NVS next annual earnings release?: The next annual earnings release for NVS is on February 3, 2027

Quarterly D&A

$3.57B$2.17B+155.18%

September 30, 2026

Summary

Current Value: As of today, NVS quarterly D&A is $3.57B, up +155.18% on September 30, 2026
Historical Performance: NVS quarterly D&A is up +144.07% year-over-year, up +14.90% over the past 3 years
All-Time High Comparison: NVS quarterly D&A is currently at its all-time high
3-Year Low Comparison: NVS quarterly D&A is +209.76% above its 3-year low of $1.15B reached on March 31, 2025
Sector Comparison: NVS quarterly D&A is higher than 100.00% of companies in Healthcare sector

Performance

NVS Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly D&A	Sep 30, 26	$3.57B	+155.2%	+144.1%	+14.9%	+146.0%
Annual D&A	Dec 31, 25	$5.35B	–	-11.8%	-20.3%	+4.7%
TTM D&A	Sep 30, 26	$7.76B	+37.3%	+43.0%	-8.9%	+58.8%
Price	Nov 6, 26	$162.55	+5.4%	+28.4%	+73.9%	+94.3%
Quarterly SG&A	Sep 30, 26	$3.06B	-5.5%	-7.2%	-0.9%	-15.3%
Quarterly Total Expenses	Sep 30, 26	$13.24B	+18.7%	+33.0%	+28.9%	+28.9%
Quarterly Operating Expenses	Sep 30, 26	$6.03B	+0.5%	-2.0%	+18.4%	+3.1%
Quarterly Revenue	Sep 30, 26	$14.44B	+0.1%	+4.0%	+22.5%	+10.8%

Quarterly D&A Highs

NVS Quarterly D&A Highs Comparison
Period	High	Date	Current
1Y	$3.57B	Sep 30, 26	at high
3Y	$3.57B	Sep 30, 26	at high
5Y	$3.57B	Sep 30, 26	at high
All	$3.57B	Sep 30, 26	at high

Quarterly D&A Lows

NVS Quarterly D&A Lows Comparison
Period	Low	Date	Current
1Y	$1.23B	Mar 31, 26	+189.9%
3Y	$1.15B	Mar 31, 25	+209.8%
5Y	$835.00M	Dec 31, 21	+328.1%
All	-$148.74M	Dec 31, 10	+2503.2%

Quarterly D&A History

Month	Value	Change
Sep 2026	$3.57B	+155.2%
Jun 2026	$1.40B	+13.6%
Mar 2026	$1.23B	-20.7%
Dec 2025	$1.55B	+6.1%
Sep 2025	$1.46B	+24.2%
Jun 2025	$1.18B	+2.2%
Mar 2025	$1.15B	-29.1%
Dec 2024	$1.63B	-17.2%
Sep 2024	$1.97B	+69.1%
Jun 2024	$1.16B	-11.6%
Mar 2024	$1.31B	-17.3%
Dec 2023	$1.59B	-49.0%
Sep 2023	$3.11B	+82.2%
Jun 2023	$1.71B	-8.9%
Mar 2023	$1.87B	+2.3%
Dec 2022	$1.83B	+9.1%
Sep 2022	$1.68B	-6.8%
Jun 2022	$1.80B	+28.3%
Mar 2022	$1.41B	+68.3%
Dec 2021	$835.00M	-42.5%
Sep 2021	$1.45B	+0.6%
Jun 2021	$1.44B	-14.9%
Mar 2021	$1.70B	+478.2%
Dec 2020	$293.50M	-83.1%
Sep 2020	$1.73B	+1.8%
Jun 2020	$1.70B	+20.8%
Mar 2020	$1.41B	-27.2%
Dec 2019	$1.94B	+38.2%
Sep 2019	$1.40B	+34.0%
Jun 2019	$1.05B	-27.4%
Mar 2019	$1.44B	-11.7%
Dec 2018	$1.63B	+18.4%
Sep 2018	$1.38B	+14.5%
Jun 2018	$1.20B	+19.2%
Mar 2018	$1.01B	+67.7%
Dec 2017	$602.00M	-59.3%
Sep 2017	$1.48B	+9.2%
Jun 2017	$1.35B	-23.8%
Mar 2017	$1.78B	+76.4%
Dec 2016	$1.01B	-33.2%
Sep 2016	$1.51B	+2.9%
Jun 2016	$1.47B	+7.1%
Mar 2016	$1.37B	+26.9%
Dec 2015	$1.08B	-20.4%
Sep 2015	$1.36B	-10.2%
Jun 2015	$1.51B	+17.7%
Mar 2015	$1.28B	+42.3%

Month	Value	Change
Dec 2014	$901.00M	-20.1%
Sep 2014	$1.13B	+4.4%
Jun 2014	$1.08B	-13.7%
Mar 2014	$1.25B	-12.0%
Dec 2013	$1.42B	+28.8%
Sep 2013	$1.10B	+16.0%
Jun 2013	$952.60M	-20.6%
Mar 2013	$1.20B	+10.3%
Dec 2012	$1.09B	-14.9%
Sep 2012	$1.28B	+10.0%
Jun 2012	$1.16B	+5.6%
Mar 2012	$1.10B	+64.2%
Dec 2011	$670.06M	-50.7%
Sep 2011	$1.36B	-3.0%
Jun 2011	$1.40B	+9.5%
Mar 2011	$1.28B	+959.6%
Dec 2010	-$148.74M	-112.1%
Sep 2010	$1.23B	+94.6%
Jun 2010	$633.20M	-16.8%
Mar 2010	$760.93M	+22.3%
Dec 2009	$622.41M	+9.0%
Sep 2009	$571.17M	+7.4%
Jun 2009	$531.60M	-0.1%
Mar 2009	$532.03M	-3.7%
Dec 2008	$552.21M	-2.5%
Sep 2008	$566.30M	-5.7%
Jun 2008	$600.75M	+3.4%
Mar 2008	$580.74M	-39.4%
Sep 2007	$958.37M	+70.5%
Jun 2007	$562.07M	+1.7%
Mar 2007	$552.56M	-1.8%
Sep 2006	$562.49M	+37.9%
Jun 2006	$408.00M	-4.7%
Mar 2006	$428.00M	-21.3%
Dec 2005	$544.00M	+9.2%
Sep 2005	$498.00M	+69.4%
Jun 2005	$294.00M	+3.2%
Mar 2005	$285.00M	-17.2%
Dec 2004	$344.00M	+4.2%
Sep 2004	$330.00M	+4.4%
Jun 2004	$316.00M	+2.3%
Mar 2004	$309.00M	-6.1%
Dec 2003	$329.00M	-8.9%
Sep 2003	$361.00M	+24.9%
Jun 2003	$289.00M	-4.9%
Mar 2003	$304.00M	-

FAQ

What is the current quarterly D&A of NVS?: As of today, NVS quarterly D&A is $3.57B
What is NVS quarterly D&A most recent change?: NVS quarterly D&A was up +155.18% on September 30, 2026
What is 1-year change in NVS quarterly D&A?: NVS quarterly D&A is up +144.07% year-over-year
How far is NVS quarterly D&A from its all-time high?: NVS quarterly D&A is currently at its all-time high
How does NVS quarterly D&A rank versus sector peers?: NVS quarterly D&A is higher than 100.00% of companies in Healthcare sector
When is NVS next earnings release?: The next earnings release for NVS is on February 3, 2027

TTM D&A

$7.76B$2.11B+37.33%

September 30, 2026

Summary

Current Value: As of today, NVS TTM D&A is $7.76B, up +37.33% on September 30, 2026
Historical Performance: NVS TTM D&A is up +43.05% year-over-year, down -8.94% over the past 3 years
All-Time High Comparison: NVS TTM D&A is currently -8.94% below its historical high of $8.52B set on September 30, 2023
3-Year Low Comparison: NVS TTM D&A is +45.03% above its 3-year low of $5.35B reached on December 31, 2025
Sector Comparison: NVS TTM D&A is higher than 99.89% of companies in Healthcare sector

Performance

NVS Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM D&A	Sep 30, 26	$7.76B	+37.3%	+43.0%	-8.9%	+58.8%
Annual D&A	Dec 31, 25	$5.35B	–	-11.8%	-20.3%	+4.7%
Quarterly D&A	Sep 30, 26	$3.57B	+155.2%	+144.1%	+14.9%	+146.0%
Price	Nov 6, 26	$162.55	+5.4%	+28.4%	+73.9%	+94.3%
TTM SG&A	Sep 30, 26	$158.17B	+1104.1%	+1086.2%	+1190.5%	+966.9%
TTM Revenue	Sep 30, 26	$55.35B	+1.0%	+1.7%	+23.9%	+8.1%

TTM D&A Highs

NVS TTM D&A Highs Comparison
Period	High	Date	Current
1Y	$7.76B	Sep 30, 26	at high
3Y	$8.52B	N/A	-8.9%
5Y	$8.52B	Sep 30, 23	-8.9%
All	$8.52B	Sep 30, 23	-8.9%

TTM D&A Lows

NVS TTM D&A Lows Comparison
Period	Low	Date	Current
1Y	$5.35B	Dec 31, 25	+45.0%
3Y	$5.35B	Dec 31, 25	+45.0%
5Y	$4.89B	N/A	+58.8%
All	$304.00M	Mar 31, 03	+2453.4%

TTM D&A History

Month	Value	Change
Sep 2026	$7.76B	+37.3%
Jun 2026	$5.65B	+4.1%
Mar 2026	$5.43B	+1.5%
Dec 2025	$5.35B	-1.4%
Sep 2025	$5.43B	-8.4%
Jun 2025	$5.93B	+0.3%
Mar 2025	$5.91B	-2.6%
Dec 2024	$6.07B	+0.7%
Sep 2024	$6.03B	-16.0%
Jun 2024	$7.18B	-7.1%
Mar 2024	$7.72B	-6.8%
Dec 2023	$8.28B	-2.9%
Sep 2023	$8.52B	+20.2%
Jun 2023	$7.09B	-1.3%
Mar 2023	$7.19B	+7.0%
Dec 2022	$6.72B	+17.4%
Sep 2022	$5.72B	+4.1%
Jun 2022	$5.50B	+7.0%
Mar 2022	$5.14B	-5.4%
Dec 2021	$5.43B	+11.1%
Sep 2021	$4.89B	-5.4%
Jun 2021	$5.17B	-4.8%
Mar 2021	$5.43B	+5.6%
Dec 2020	$5.14B	-24.2%
Sep 2020	$6.78B	+5.1%
Jun 2020	$6.45B	+11.3%
Mar 2020	$5.80B	-0.5%
Dec 2019	$5.83B	+5.5%
Sep 2019	$5.52B	+0.4%
Jun 2019	$5.50B	-2.8%
Mar 2019	$5.65B	+8.3%
Dec 2018	$5.22B	+24.5%
Sep 2018	$4.19B	-2.3%
Jun 2018	$4.29B	-3.4%
Mar 2018	$4.44B	-14.7%
Dec 2017	$5.21B	-7.2%
Sep 2017	$5.62B	-0.5%
Jun 2017	$5.65B	-1.9%
Mar 2017	$5.76B	+7.6%
Dec 2016	$5.35B	-1.3%
Sep 2016	$5.42B	+2.9%
Jun 2016	$5.27B	-0.8%
Mar 2016	$5.31B	+1.7%
Dec 2015	$5.23B	+3.5%
Sep 2015	$5.05B	+4.7%
Jun 2015	$4.82B	+9.8%
Mar 2015	$4.39B	+0.7%

Month	Value	Change
Dec 2014	$4.36B	-10.7%
Sep 2014	$4.88B	+0.5%
Jun 2014	$4.86B	+2.7%
Mar 2014	$4.73B	+1.1%
Dec 2013	$4.68B	+7.7%
Sep 2013	$4.35B	-3.8%
Jun 2013	$4.52B	-4.4%
Mar 2013	$4.73B	+2.2%
Dec 2012	$4.63B	+9.9%
Sep 2012	$4.21B	-1.9%
Jun 2012	$4.29B	-5.3%
Mar 2012	$4.53B	-3.8%
Dec 2011	$4.71B	+21.1%
Sep 2011	$3.89B	+3.3%
Jun 2011	$3.76B	+25.6%
Mar 2011	$3.00B	+20.9%
Dec 2010	$2.48B	-23.7%
Sep 2010	$3.25B	+25.6%
Jun 2010	$2.59B	+4.1%
Mar 2010	$2.49B	+10.1%
Dec 2009	$2.26B	+3.2%
Sep 2009	$2.19B	+0.2%
Jun 2009	$2.18B	-3.1%
Mar 2009	$2.25B	-2.1%
Dec 2008	$2.30B	+31.6%
Sep 2008	$1.75B	-18.3%
Jun 2008	$2.14B	+1.8%
Mar 2008	$2.10B	+1.4%
Sep 2007	$2.07B	+23.6%
Jun 2007	$1.68B	+10.1%
Mar 2007	$1.52B	-21.6%
Sep 2006	$1.94B	+3.4%
Jun 2006	$1.88B	+6.5%
Mar 2006	$1.76B	+8.8%
Dec 2005	$1.62B	+14.1%
Sep 2005	$1.42B	+13.4%
Jun 2005	$1.25B	-1.7%
Mar 2005	$1.28B	-1.8%
Dec 2004	$1.30B	+1.2%
Sep 2004	$1.28B	-2.4%
Jun 2004	$1.32B	+2.1%
Mar 2004	$1.29B	+0.4%
Dec 2003	$1.28B	+34.5%
Sep 2003	$954.00M	+60.9%
Jun 2003	$593.00M	+95.1%
Mar 2003	$304.00M	-

FAQ

What is the current TTM D&A of NVS?: As of today, NVS TTM D&A is $7.76B
What is NVS TTM D&A most recent change?: NVS TTM D&A was up +37.33% on September 30, 2026
What is 1-year change in NVS TTM D&A?: NVS TTM D&A is up +43.05% year-over-year
How far is NVS TTM D&A from its all-time high?: NVS TTM D&A is currently -8.94% below its historical high of $8.52B set on September 30, 2023
How does NVS TTM D&A rank versus sector peers?: NVS TTM D&A is higher than 99.89% of companies in Healthcare sector
When is NVS next earnings release?: The next earnings release for NVS is on February 3, 2027

Data Sources & References

NVS Official Website www.novartis.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm
NVS Profile on Yahoo Finance finance.yahoo.com/quote/NVS
NVS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvs